A number of other equities research analysts also recently issued reports on PUMP. Raymond James increased their price objective on shares of Asante Solutions from $24.00 to $25.00 and gave the stock a strong-buy rating in a research note on Thursday. Stephens increased their price objective on shares of Asante Solutions to $25.00 and gave the stock an overweight rating in a research note on Thursday. Zacks Investment Research downgraded shares of Asante Solutions from a hold rating to a strong sell rating in a research note on Wednesday, October 17th. Stifel Nicolaus assumed coverage on shares of Asante Solutions in a research note on Monday, September 10th. They set a buy rating and a $18.00 price objective on the stock. Finally, Royal Bank of Canada set a $22.00 price objective on shares of Asante Solutions and gave the stock a buy rating in a research note on Thursday. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of Buy and an average price target of $22.23.
Shares of PUMP stock traded down $0.01 on Friday, hitting $18.60. The company’s stock had a trading volume of 1,883,740 shares, compared to its average volume of 1,719,347. Asante Solutions has a fifty-two week low of $14.00 and a fifty-two week high of $22.88.
Asante Solutions (NASDAQ:PUMP) last announced its quarterly earnings data on Tuesday, November 6th. The company reported $0.53 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.54 by ($0.01). The business had revenue of $434.00 million for the quarter, compared to analysts’ expectations of $447.84 million. The firm’s quarterly revenue was up 53.5% on a year-over-year basis. During the same quarter last year, the firm earned $0.25 EPS.
In other news, Director Spencer D. Armour III sold 22,500 shares of the stock in a transaction dated Tuesday, October 2nd. The shares were sold at an average price of $17.14, for a total value of $385,650.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Hedge funds have recently bought and sold shares of the company. Riverhead Capital Management LLC bought a new position in shares of Asante Solutions in the second quarter worth about $152,000. Everence Capital Management Inc. bought a new position in shares of Asante Solutions in the second quarter worth about $170,000. Amalgamated Bank bought a new position in shares of Asante Solutions in the second quarter worth about $179,000. Dorsey & Whitney Trust CO LLC bought a new position in Asante Solutions in the 3rd quarter valued at approximately $189,000. Finally, Flinton Capital Management LLC raised its holdings in Asante Solutions by 423.7% in the 2nd quarter. Flinton Capital Management LLC now owns 14,496 shares of the company’s stock valued at $227,000 after buying an additional 11,728 shares during the last quarter.
About Asante Solutions
Asante Solutions, Inc is a medical device company. The Company is a manufacturer of Asante Snap Insulin Pump System (Snap system), which is a pump featuring a modular design with pre-filled insulin cartridges and disposable pump bodies, utilized in combination with a controller. The Snap system comprises four components: the Snap system controller, a disposable pump body, disposable pre-filled insulin cartridges and disposable infusion sets.
Read More: What Factors Can Affect Return on Equity?
Receive News & Ratings for Asante Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Asante Solutions and related companies with MarketBeat.com's FREE daily email newsletter.